Janet K. Sluggett , Daria S. Gutteridge , Annabel Calder , Georgina A. Hughes , Elizabeth Manias , Shanthi A. Ramanathan , Kurtis Budden , Ingrid Sketris , Sara Javanparast
{"title":"Evaluation of the Aged Care On-site Pharmacist (ACOP) program in Australian residential aged care homes: Key considerations and next steps","authors":"Janet K. Sluggett , Daria S. Gutteridge , Annabel Calder , Georgina A. Hughes , Elizabeth Manias , Shanthi A. Ramanathan , Kurtis Budden , Ingrid Sketris , Sara Javanparast","doi":"10.1016/j.sapharm.2025.10.006","DOIUrl":null,"url":null,"abstract":"<div><div>Older people who live in residential aged care homes (RACHs) often experience polypharmacy and use potentially inappropriate medications. In response to issues identified by a recent national inquiry that identified the need to improve medication management practices in Australian RACHs, a federal government-subsidized initiative to enable clinical pharmacists to practice on-site in Australian RACHs has recently been launched. This new optional program has been funded to enhance quality use of medicines and resident's health and wellbeing in Australian RACHs. This commentary discusses the need for a comprehensive evaluation of this population-based and publicly subsidized initiative to improve medication management in RACHs. It presents a program logic model that outlines the required activities, key outputs and anticipated impacts of Australia's RACH on-site pharmacist program to aid program implementers and beneficiaries to plan, communicate, and evaluate this new program. The program logic model presented can also inform the actions of policy makers and program implementers in other countries who are involved in planning, execution and evaluation of new pharmacist-led interventions or programs in RACHs.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 2","pages":"Pages 348-353"},"PeriodicalIF":3.4000,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Research in Social & Administrative Pharmacy","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1551741125004747","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/14 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0
Abstract
Older people who live in residential aged care homes (RACHs) often experience polypharmacy and use potentially inappropriate medications. In response to issues identified by a recent national inquiry that identified the need to improve medication management practices in Australian RACHs, a federal government-subsidized initiative to enable clinical pharmacists to practice on-site in Australian RACHs has recently been launched. This new optional program has been funded to enhance quality use of medicines and resident's health and wellbeing in Australian RACHs. This commentary discusses the need for a comprehensive evaluation of this population-based and publicly subsidized initiative to improve medication management in RACHs. It presents a program logic model that outlines the required activities, key outputs and anticipated impacts of Australia's RACH on-site pharmacist program to aid program implementers and beneficiaries to plan, communicate, and evaluate this new program. The program logic model presented can also inform the actions of policy makers and program implementers in other countries who are involved in planning, execution and evaluation of new pharmacist-led interventions or programs in RACHs.
期刊介绍:
Research in Social and Administrative Pharmacy (RSAP) is a quarterly publication featuring original scientific reports and comprehensive review articles in the social and administrative pharmaceutical sciences. Topics of interest include outcomes evaluation of products, programs, or services; pharmacoepidemiology; medication adherence; direct-to-consumer advertising of prescription medications; disease state management; health systems reform; drug marketing; medication distribution systems such as e-prescribing; web-based pharmaceutical/medical services; drug commerce and re-importation; and health professions workforce issues.